SOPHARMA AD - Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 17 / 2017

Date of issue: 2017-04-20

Short name of the issuer

SOPHARMA AD

Subject

Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00

Official market - legal basis

art. 17. 1 MAR.

Unofficial market - legal basis

Contents of the report:

Sopharma AD (the “Company”) hereby notifies all shareholders of the Company, that the Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00 will take place at Sopharma Business Towers, Building B, floor 3, 5 Lachezar Stanchev Str.. The registration begins at 9:30. All shareholders of the company are invited to participate at the General Meeting in person or by proxy. As a prerequisite for the technical provisioning of the Extraordinary General Meeting of Shareholders, copies of all letters of attorney must be presented to the Company on paper or electronically at [email protected] by the end of the workday preceding the date of the AGM, namely 5 p.m. on 21 April 2017. We would like to thank all shareholders for their understanding and cooperation.

Annexes

File Description

Current report _ SPH EGM - 24.04.2017.doc Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2017-04-20 Ognian Donev Executive director